MichelleHladunewich Canada

Dr. Hladunewich completed her Doctor of Medicine at the University of Alberta, her internal medicine training at the University of Toronto and then proceeded to complete her Critical Care and Nephrology Fellowships at Stanford University Medical Center. In addition to her research training in glomerular physiology, she completed a Master’s of Science in Clinical Investigation at Stanford University. Dr. Hladunewich joined the University of Toronto in 2003, and was promoted to Associate Professor in 2013 and to Full Professor in 2019. She is the Clinical Trials Director at the Toronto Glomerulonephritis Clinic and Registry. She is the medical lead for the Kidney Disease and Pregnancy Clinic (PreKid Clinic), and the Physician in Chief of Medicine at Sunnybrook Health Sciences Centre. Her research program includes studies in glomerular-based disease as well as pregnancy related kidney disease. Dr. Hladunewich is currently the Ontario Renal Network Medical Lead for Glomerulonephritis and Specialty Clinics.
Upload Picture
First Name
Michelle
Last Name
Hladunewich
Institution
Country.
Canada

Thursday, February 6, 2025

Time Session
1 p.m.
2:30 p.m.
MichelleHladunewich Chair Canada
ShilpanjaliJesudason Chair Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
  • Welcome and Background on Obstetric Nephrology Evolution
    MichelleHladunewich Speaker Canada
  • Overview of the TT Program and Toolkit Launch
    ShilpanjaliJesudason Speaker Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia
  • Trainer Perspective
    GhadaAnkawi Speaker King Abdulaziz University Saudi Arabia
  • Trainer Perspective
    DIVYABAJPAI Speaker Professor, Department of Nephrology, Seth G.S.M.C. and K.E.M. Hospital, Mumbai, IndiaIndia
  • Panel Discussion, Questions and Group Discussion
Mogra Hall A 404